Event Type: Earnings Conference Call for all Investors/General public
Event Date and Time: Held on September 22, 2026 (specific time not mentioned in disclosure)
Purpose of Event: Discussion of Operational and Financial Performance of the Company for the 1st Quarter ended June 30, 2026
Timing Relative to Earnings: The call was held post-results, as it discusses performance for the quarter already ended (June 30, 2026)
Management Participants: Not specified in the disclosure
Availability of Materials: Audio recording of the earnings conference call is available. No mention of presentation deck, transcript, or additional materials
UPSI Statement: The disclosure does not contain any specific statement regarding unpublished price sensitive information (UPSI)
Additional Notes Section
Attachments: The disclosure mentions "Encl: As above" but does not specify any additional attachments beyond the letter itself
Financial Data Disclosure: No financial data, figures, or performance metrics are disclosed in this announcement. It solely intimates the availability of the conference call recording
Access Information: The audio recording is available on the company's investor relations website (https://investor.symbiotec.com/performance?tab=quarterly) and via a direct hosted link (https://cornflowerblue-penguin-553951.hostingersite.com/uploads/1790063932954-543036402.mp3)
